GLP 1 receptor agonists should not be combined with DPP 4 inhibitors, as there is no added glucose lowering benefit beyond that of the GLP 1 RA alone. Both drug classes work through overlapping mechanisms involving SRx Exploring LDN for Autoimmune Support Low Dose Naltrexone (LDN) is gaining attention for its potential to support patients with autoimmune conditions, such as Multiple Sclerosis, Rheumatoid Arthritis, Hashimoto's, Crohn's disease, and Ozempic Sulfur Burps & Bloating: Why Food Feels Stuck The Truth About GLP 1s: Assessing the Risk of Medullary Thyroid Cancer in Humans glp 1 perimenopause GLP 1 Medications for Women in Perimenopause: What I Tell My Patients